祥生医疗
(688358)
| 流通市值：37.34亿 | | | 总市值：37.34亿 |
| 流通股本：1.12亿 | | | 总股本：1.12亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 362,245,220.14 | 247,570,088.35 | 140,596,727.46 | 483,841,135.63 |
| 营业收入 | 362,245,220.14 | 247,570,088.35 | 140,596,727.46 | 483,841,135.63 |
| 二、营业总成本 | 265,916,746.04 | 164,977,311.94 | 88,993,213.8 | 344,438,412.95 |
| 营业成本 | 147,964,861.72 | 98,814,720.18 | 55,368,036.53 | 199,310,909.05 |
| 税金及附加 | 3,612,804.07 | 2,461,913.21 | 1,106,457.03 | 4,024,849.09 |
| 销售费用 | 39,476,204.72 | 25,261,643.13 | 12,432,793.26 | 52,824,392.6 |
| 管理费用 | 27,172,040.53 | 18,769,693.88 | 7,878,988.58 | 34,932,334.24 |
| 研发费用 | 61,760,390.24 | 39,069,886.01 | 19,658,619.98 | 77,071,759.72 |
| 财务费用 | -14,069,555.24 | -19,400,544.47 | -7,451,681.58 | -23,725,831.75 |
| 其中:利息费用 | 297,302.28 | 208,883.69 | 191,988.6 | 357,351.83 |
| 其中:利息收入 | 20,523,681.22 | 14,773,173.59 | 7,004,670.15 | 18,988,335.79 |
| 加:公允价值变动收益 | 263,783.4 | 272,001.82 | 490,525.97 | 2,927,532.39 |
| 加:投资收益 | 4,784,941.62 | 3,168,541 | 1,424,616.2 | 10,613,759.12 |
| 资产处置收益 | 3,149,775.04 | 3,146,858.82 | - | 3,022,739.7 |
| 资产减值损失(新) | -974,947.4 | -664,518.48 | -103,103.6 | -5,534,498.32 |
| 信用减值损失(新) | -3,864,255.69 | -3,078,268.08 | -2,017,065.08 | -3,571,489.89 |
| 其他收益 | 8,203,394.72 | 6,667,370.93 | 1,008,802.63 | 15,362,274.62 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 107,891,165.79 | 92,104,762.42 | 52,407,289.78 | 162,223,040.3 |
| 加:营业外收入 | 7,000.6 | 7,000.6 | 7,000.6 | 406,091.49 |
| 减:营业外支出 | 245,441.91 | 236,493.5 | 2,937.29 | 435,031.27 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 107,652,724.48 | 91,875,269.52 | 52,411,353.09 | 162,194,100.52 |
| 减:所得税费用 | 9,244,171.78 | 10,531,624.62 | 6,871,880.34 | 15,713,413.11 |
| 六、净利润 | 98,408,552.7 | 81,343,644.9 | 45,539,472.75 | 146,480,687.41 |
| 持续经营净利润 | 98,408,552.7 | 81,343,644.9 | 45,539,472.75 | 146,480,687.41 |
| 归属于母公司股东的净利润 | 98,408,552.7 | 81,343,644.9 | 45,539,472.75 | 146,480,687.41 |
| (一)基本每股收益 | 0.88 | 0.73 | 0.41 | 1.33 |
| (二)稀释每股收益 | 0.88 | 0.73 | 0.41 | 1.33 |
| 八、其他综合收益 | -3,326,913.66 | 3,357.96 | 5,596.95 | 1,229.69 |
| 归属于母公司股东的其他综合收益 | -3,326,913.66 | 3,357.96 | 5,596.95 | 1,229.69 |
| 九、综合收益总额 | 95,081,639.04 | 81,347,002.86 | 45,545,069.7 | 146,481,917.1 |
| 归属于母公司股东的综合收益总额 | 95,081,639.04 | 81,347,002.86 | 45,545,069.7 | 146,481,917.1 |
| 公告日期 | 2024-10-31 | 2024-08-29 | 2024-04-19 | 2024-04-19 |
| 审计意见(境内) | | | | 标准无保留意见 |